2023年1月5日

2022年，全球信使RNA (mRNA)疫苗和治疗市场估值为116.3亿美元，预计到2028年将达到263.4亿美元信使核糖核酸(mRNA)是指基因组中作为细胞蛋白质合成基础的单个蛋白质编码基因的术语。mRNA疫苗和治疗是在实验室中利用哺乳动物细胞制成的，具有良好的免疫特性。感染预防mRNA疫苗、传染病治疗mRNA疫苗、定制化癌症治疗mRNA疫苗、标准化癌症治疗mRNA疫苗是常见的疫苗和治疗类型。它们被注射到体内，以激活检测病毒的免疫传感器，并使细胞产生病毒抗原蛋白。这能改善B细胞和t细胞的反应，有助于身体的免疫力。从2022年到2028年，全球信使RNA (mRNA)疫苗和疗法市场规模将以14.60%的复合年增长率增长，信使RNA疫苗和疗法采用新技术产生，这些新技术更有效地对抗感染，具有更高的效力，提高免疫原性，并且比传统药物相对更具成本效益。推动全球信使RNA (mRNA)疫苗和治疗市场发展的关键因素之一是糖尿病、结核病、癌症和心血管疾病(cvd)等医学疾病的日益流行。此外，该行业还受益于对埃博拉、流感、艾滋病毒和其他病毒性疾病治疗药物和疫苗的需求不断增长。随着针对COVID-19的mRNA疫苗和疗法的推出和广泛使用，2020年是mRNA技术平台的一个分水岭。因此，到2020年，mRNA平台的综合市场估值迅速增长。 The increase in market value reflects expectations that mRNA technology will give far more than the current COVID-19 preventive vaccines. Global Messenger RNA (mRNA) Vaccines & Therapeutics Market Segmentation Analysis: By Type, the market is bifurcated into Infection Prevention mRNA Vaccine, Infectious Disease Treatment mRNA Vaccine, Individualized Cancer Treatment mRNA Vaccine, and Standardization of Cancer Treatment mRNA Vaccine. By Application, Cancer, Infectious Diseases, and Others are the major segments covered in our report. As per our estimates, Infectious Diseases hold a significant share in the market and are estimated to remain dominant throughout the forecasted period. By End User, we have studied the market for hospitals, Clinics, Diagnostics Centers, and Others. As per our analysis, clinics and diagnostic centers are gaining traction with the advancement of technology applications. However, hospitals tend to remain dominant throughout the study period. By Region, North America, Europe, Asia-Pacific, and Rest of the World. During the forecast period, North America is estimated to monopolize the Global Messenger RNA (mRNA) Vaccines & Therapeutics Market. The market in North America is contrived by an increase in demand for COVID-19 mRNA vaccines, major players operating in the US, and an exponential rise in the number of COVID-19 cases in the US. Key Players: Pfizer, GlaxoSmithKline, Daiichi Sankyo Company, Limited, Intellia Therapeutics, Moderna Inc, CureVac N.V., Arcturus Therapeutics Holdings, and BioNTech are the prominent companies in the Global Messenger RNA (mRNA) Vaccines & Therapeutics Market examined in our analysis. In addition, we have discussed the competition landscape section of the study, which included an overview, the latest development strategies, and market revenue analysis of the above-mentioned worldwide companies. Surprisingly, the major firms invest in mRNA technologies since they can integrate numerous molecules into a therapeutic drug, which is a huge growth factor. Key Players: